Gene expression profiling based identification of genomic signature of highrisk multiple myeloma and uses thereof

Details for Australian Patent Application No. 2009238613 (hide)

Owner The Board of Trustees of the University of Arkansas

Inventors Shaughnessy Jr., John D.; Zhou, Yiming; Barlogie, Bart; Zhan, Fenghuang; Burington, Bart E.

Agent Callinan

Pub. Number AU-A-2009238613

PCT Pub. Number WO2009/131710

Priority 12/148,985 24.04.08 US

Filing date 24 April 2009

Wipo publication date 29 October 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/131710 Priority application(s): WO2009/131710

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238625-Method of making high purity lithium hydroxide and hydrochloric acid

2009238607-Nanostructures suitable for sequestering cholesterol